Plasma IL-17A is increased in patients with critical MIS-C and associated to in-hospital mortality.

Journal: Frontiers in immunology
PMID:

Abstract

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe post-COVID-19 complication with multiple phenotypes.

Authors

  • Emmerson C F de Farias
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Luciana M P P do Nascimento
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Manoel J C Pavão Junior
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Dalila C A Pavão
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Ana P S Pinheiro
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Andreza H O Pinheiro
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Marília C B Alves
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Kíssila M M M Ferraro
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Larisse F Q Aires
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Luana G Dias
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Mayara M M Machado
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Michaelle J D Serrão
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Raphaella R Gomes
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Sara M P de Moraes
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Gabriela C L Pontes
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Railana D F P Carvalho
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Cristiane T C Silva
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Carla M A das Neves
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Joyce C L Dos Santos
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Adriana M B de Sousa
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Leda L da Silva
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Mary L F M F de Mello
    Division of Pediatric Intensive Care, Department of Pediatrics, Fundação Santa Casa de Misericórdia do Pará, Belém, Brazil.
  • Patricia B Carvalho
    Division of Pediatric Intensive Care, Departament of Pediatrics, Fundação Hospital das Clínicas Gaspar Viana, Belém, Brazil.
  • Renata de B Braga
    Division of Pediatric Intensive Care, Departament of Pediatrics, Fundação Hospital das Clínicas Gaspar Viana, Belém, Brazil.
  • Kathia de O Harada
    Division of Pediatric Intensive Care, Departament of Pediatrics, Fundação Hospital das Clínicas Gaspar Viana, Belém, Brazil.
  • Maria C A Justino
    Clinical Research Unit, Health Surveillance Secretariat, Brazilian Ministry of Health, Instituto Evandro Chagas, Ananindeua, Brazil.
  • Iran B Costa
    Immunology Laboratory, Virology Unit, Instituto Evandro Chagas, Ananindeua, Brazil.
  • Igor Brasil-Costa
    Immunology Laboratory, Virology Unit, Instituto Evandro Chagas, Ananindeua, Brazil.
  • Marta C Monteiro
    Pharmaceutical Science Post-Graduation Program and Neuroscience and Cell Biology Graduate Program, Health Science Institute, Federal University of Pará/UFPA, Belém, Brazil.
  • Gleice Clemente
    Division of Pediatric Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Maria Teresa Terreri
    Division of Pediatric Rheumatology, Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.